SC 13G Filing

Company

CytomX Therapeutics, Inc.

Filed

July 25, 2022

Accession Number

0001214659-22-009141

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →